logo-loader
viewMediclinic International Plc

Mediclinic weak as first half profit falls due to a smaller contribution from its Swiss operation

Mediclinic’s chief executive Ronnie van der Merwe commented: "The poor performance in Switzerland more than outweighed the revenue growth and margin expansion delivered by the Southern Africa and the Middle East divisions"

Hospital
Mediclinic posted a pre-tax loss of £150mln in the first half, against a £10mln loss a year earlier, as revenue fell by 1.4% to £1.39bn

Mediclinic International Plc (LON:MDC) shares fell on Thursday as the firm saw its first-half profit decline due to a smaller contribution from its Swiss operation, Hirslanden.

The FTSE 250-listed private healthcare group saw its adjusted underlying earnings (EBITDA) fall by 8% to £213mln for the six months to September 30, down from £232mln a year earlier.

READ: Barclays has little confidence in the Mediclinic recovery story

The London and Johannesburg-quoted firm posted a pre-tax loss of £150mln in the first half, against a £10mln loss a year earlier, as revenue fell by 1.4% to £1.39bn from £1.41bn.

In Switzerland, the company’s adjusted EBITDA fell by 17% to SFr118mln despite revenue in the country rising by 1% to SFr826mln.

Mediclinic’s chief executive Ronnie van der Merwe commented: "The poor performance in Switzerland more than outweighed the revenue growth and margin expansion delivered by the Southern Africa and the Middle East divisions."

The group kept its interim dividend unchanged at 3.20p per share.

In early morning trading, Mediclinic shares were 3.9% lower at 341.40p.

In a separate announcement, Mediclinic also announced that its senior independent non-executive director Desmond Smith will retire from the board at the end of its annual general meeting expected to take place on 24 July 2019.

Quick facts: Mediclinic International Plc

Price: 396.5 GBX

LSE:MDC
Market: LSE
Market Cap: £2.92 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

NQ Minerals' David Lenigas focused on restructuring debt and upping profits...

NQ Minerals PLC's (LON:NQMI) David Lenigas speaks to Proactive London's Andrew Scott soon after taking over as chairman at the Australia-focused mining group. Production and exploration plans aside, Lenigas also says they're in advanced talks to replace on more favourable terms all the debt...

10 hours, 33 minutes ago

2 min read